Literature DB >> 22170953

Statins and influenza: can we move forward?

Edward E Walsh.   

Abstract

Mesh：

Substances：

Year:  2011        PMID： 22170953      PMCID： PMC3242742          DOI： 10.1093/infdis/jir693

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  32 in total

Review 1.  Mortality benefits of influenza vaccination in elderly people: an ongoing controversy.

Authors:  Lone Simonsen; Robert J Taylor; Cecile Viboud; Mark A Miller; Lisa A Jackson
Journal:  Lancet Infect Dis       Date:  2007-10       Impact factor: 25.071

2.  Temporal relationship between influenza infections and subsequent first-ever stroke incidence.

Authors:  André M Toschke; Peter U Heuschmann; Oliver Wood; Charles D A Wolfe
Journal:  Age Ageing       Date:  2008-11-21       Impact factor: 10.668

Review 3.  Regulation of different inflammatory diseases by impacting the mevalonate pathway.

Authors:  Robert Zeiser; Kristina Maas; Sawsan Youssef; Christoph Dürr; Lawrence Steinman; Robert S Negrin
Journal:  Immunology       Date:  2009-05       Impact factor: 7.397

4.  Influenza vaccination and risk of community-acquired pneumonia in immunocompetent elderly people: a population-based, nested case-control study.

Authors:  Michael L Jackson; Jennifer C Nelson; Noel S Weiss; Kathleen M Neuzil; William Barlow; Lisa A Jackson
Journal:  Lancet       Date:  2008-08-02       Impact factor: 79.321

5.  Antiviral therapy and outcomes of influenza requiring hospitalization in Ontario, Canada.

Authors:  Allison McGeer; Karen A Green; Agron Plevneshi; Altynay Shigayeva; Nilofar Siddiqi; Janet Raboud; Donald E Low
Journal:  Clin Infect Dis       Date:  2007-12-15       Impact factor: 9.079

6.  Influenza and COPD mortality protection as pleiotropic, dose-dependent effects of statins.

Authors:  Floyd J Frost; Hans Petersen; Kristine Tollestrup; Betty Skipper
Journal:  Chest       Date:  2007-04       Impact factor: 9.410

Review 7.  Update on statin-mediated anti-inflammatory activities in atherosclerosis.

Authors:  Fabrizio Montecucco; François Mach
Journal:  Semin Immunopathol       Date:  2009-05-05       Impact factor: 9.623

8.  Adherence to lipid-lowering therapy and the use of preventive health services: an investigation of the healthy user effect.

Authors:  M Alan Brookhart; Amanda R Patrick; Colin Dormuth; Jerry Avorn; William Shrank; Suzanne M Cadarette; Daniel H Solomon
Journal:  Am J Epidemiol       Date:  2007-05-15       Impact factor: 4.897

9.  A Canadian Critical Care Trials Group project in collaboration with the international forum for acute care trialists - Collaborative H1N1 Adjuvant Treatment pilot trial (CHAT): study protocol and design of a randomized controlled trial.

Authors:  Karen E A Burns; Clarence Chant; Orla Smith; Brian Cuthbertson; Robert Fowler; Deborah J Cook; Peter Kruger; Steve Webb; Jamal Alhashemi; Guillermo Dominguez-Cherit; Carlos Zala; Gordon D Rubenfeld; John C Marshall
Journal:  Trials       Date:  2011-03-09       Impact factor: 2.279

10.  Estimates of US influenza-associated deaths made using four different methods.

Authors:  William W Thompson; Eric Weintraub; Praveen Dhankhar; Po-Yung Cheng; Lynnette Brammer; Martin I Meltzer; Joseph S Bresee; David K Shay
Journal:  Influenza Other Respir Viruses       Date:  2009-01       Impact factor: 4.380
View more
  5 in total

1.  Effect of statin treatments on highly pathogenic avian influenza H5N1, seasonal and H1N1pdm09 virus infections in BALB/c mice.

Authors:  Yohichi Kumaki; John D Morrey; Dale L Barnard
Journal:  Future Virol       Date:  2012-08       Impact factor: 1.831

Review 2.  The controversy over H5N1 transmissibility research: an opportunity to define a practical response to a global threat.

Authors:  David S Fedson; Steven M Opal
Journal:  Hum Vaccin Immunother       Date:  2013-02-07       Impact factor: 3.452

3.  Skin immunization by microneedle patch overcomes statin-induced suppression of immune responses to influenza vaccine.

Authors:  Elena V Vassilieva; Shelly Wang; Song Li; Mark R Prausnitz; Richard W Compans
Journal:  Sci Rep       Date:  2017-12-19       Impact factor: 4.379

4.  Human H5N1 influenza infections in Cambodia 2005-2011: case series and cost-of-illness.

Authors:  Karen Humphries-Waa; Tom Drake; Anthony Huszar; Marco Liverani; Khieu Borin; Sok Touch; Teng Srey; Richard Coker
Journal:  BMC Public Health       Date:  2013-06-06       Impact factor: 3.295

Review 5.  Lipids in innate antiviral defense.

Authors:  John W Schoggins; Glenn Randall
Journal:  Cell Host Microbe       Date:  2013-10-16       Impact factor: 21.023
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.